Naoko Adachi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Naoko Adachi has a total of 129 co-authors. Here are the top co-authors by number of shared publications:
Naoaki Saito
Laboratory of Molecular Pharmacology, Biosignal Research Center Kobe University Kobe Japan
18 shared publications- Takahiro Seki
Department of Chemico-Pharmacological Sciences, Graduate School of Pharmaceutical Sciences, Kumamoto University, 5–1 Oe-Honmachi, Chuo-ku, Kumamoto 862–0973, Japan
15 shared publications Norio Sakai
Molecular and Pharmacological Neuroscience, Graduate School of Biomedical Sciences, Hiroshima University, Japan
12 shared publicationsHideyuki Takahashi
Departments of Neurology and Neurobiology, Yale University School of Medicine, United States
8 shared publications- Naoaki Saito
Laboratory of Molecular Pharmacology, Biosignal Research Center, Kobe University, Kobe 657-8501, Japan
8 shared publications - Shigeru Tanaka
Department of Molecular and Pharmacological Neuroscience, Hiroshima University Graduate School of Biomedical and Health Sciences, Hiroshima, Japan
8 shared publications
Latest Publications
- 25 November 2025
- Published by Wiley in Journal of Neurochemistry
- Vol. 169 (11) , e70305
Age‐Progressive Synaptic and Axonal Dysregulation Induced by Purkinje Cell–Targeted AAV Expression of SCA14 PKCγ in Mice
Spinocerebellar ataxia type 14 (SCA14) is an autosomal‐dominant disorder caused by more than 80 PRKCG missense variants encoding protein kinase Cγ (PKCγ), a serine/threonine kinase highly enriched in Purkinje cells (PCs). Despite typically late onset and slow progression, the molecular basis of age‐related decline remains unclear. We used a somatic in vivo approach to express wild‐type (WT) PKCγ–GFP or the prototypical G128D PKCγ–GFP selectively in PCs of neonatal mice via an adeno‐associated virus (AAV) under a PC‐specific promoter. G128D PKCγ–GFP formed cytoplasmic aggregates, mislocalized PCs during development, and produced gait deficits by 4 weeks that worsened with age, despite preserved PC counts and overall cerebellar volume at 1.5 years. Immunohistochemistry revealed a selective vulnerability of climbing‐fiber (CF) input: vesicular glutamate transporter 2 (VGLUT2), a marker of CF synapses, declined significantly from 12 to 60 weeks in G128D mice, and the VGLUT2‐positive innervation field was narrower than age‐matched WT at both time points. By contrast, the glutamate/aspartate transporter GLAST in Bergmann‐glial radial processes was reduced predominantly at 12 weeks in G128D mice. The δ2 glutamate receptor (GluD2) at parallel fibers and glial fibrillary acidic protein (GFAP) decreased with age but were comparable between expression conditions. Notably, aggregated mutant PKCγ accumulated within the axon initial segment (AIS), whose architecture progressively deteriorated; the altered AIS excluded PKCγ–GFP from distal axons and, by 60 weeks, was associated with reduced delivery of the vesicular GABA transporter (VGAT) to deep cerebellar nuclei (DCN), consistent with impaired anterograde transport. Hence, rather than overt neuronal loss, the cumulative burden of G128D‐specific CF/axonal deficits and age‐accentuated circuit and glial changes—reduced GLAST function and decreased GluD2—accounts for the worsening motor phenotype. This AAV‐based system provides a practical platform to dissect late‐onset pathogenic mechanisms and evaluate therapeutic strategies in vivo. image
- 25 November 2025
- Published by Wiley in Journal of Neurochemistry
- Vol. 169 (11) , e70305
Age‐Progressive Synaptic and Axonal Dysregulation Induced by Purkinje Cell–Targeted AAV Expression of SCA14 PKCγ in Mice
Spinocerebellar ataxia type 14 (SCA14) is an autosomal‐dominant disorder caused by more than 80 PRKCG missense variants encoding protein kinase Cγ (PKCγ), a serine/threonine kinase highly enriched in Purkinje cells (PCs). Despite typically late onset and slow progression, the molecular basis of age‐related decline remains unclear. We used a somatic in vivo approach to express wild‐type (WT) PKCγ–GFP or the prototypical G128D PKCγ–GFP selectively in PCs of neonatal mice via an adeno‐associated virus (AAV) under a PC‐specific promoter. G128D PKCγ–GFP formed cytoplasmic aggregates, mislocalized PCs during development, and produced gait deficits by 4 weeks that worsened with age, despite preserved PC counts and overall cerebellar volume at 1.5 years. Immunohistochemistry revealed a selective vulnerability of climbing‐fiber (CF) input: vesicular glutamate transporter 2 (VGLUT2), a marker of CF synapses, declined significantly from 12 to 60 weeks in G128D mice, and the VGLUT2‐positive innervation field was narrower than age‐matched WT at both time points. By contrast, the glutamate/aspartate transporter GLAST in Bergmann‐glial radial processes was reduced predominantly at 12 weeks in G128D mice. The δ2 glutamate receptor (GluD2) at parallel fibers and glial fibrillary acidic protein (GFAP) decreased with age but were comparable between expression conditions. Notably, aggregated mutant PKCγ accumulated within the axon initial segment (AIS), whose architecture progressively deteriorated; the altered AIS excluded PKCγ–GFP from distal axons and, by 60 weeks, was associated with reduced delivery of the vesicular GABA transporter (VGAT) to deep cerebellar nuclei (DCN), consistent with impaired anterograde transport. Hence, rather than overt neuronal loss, the cumulative burden of G128D‐specific CF/axonal deficits and age‐accentuated circuit and glial changes—reduced GLAST function and decreased GluD2—accounts for the worsening motor phenotype. This AAV‐based system provides a practical platform to dissect late‐onset pathogenic mechanisms and evaluate therapeutic strategies in vivo. image
- Open Access
- 10 January 2025
- Published by Elsevier in Journal of Lipid Research
- Vol. 66 (2) , 100743
A facile assay for zDHHC palmitoyl transferase activation elucidates effects of mutation and modification
- 10 January 2025
- Published by Elsevier in Journal of Lipid Research
- Vol. 66 (2) , 100743
Open AccessA facile assay for zDHHC palmitoyl transferase activation elucidates effects of mutation and modification
- 14 April 2023
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 662, 58-65
S-Palmitoylation of the serotonin transporter promotes its cell surface expression and serotonin uptake
- 14 April 2023
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 662, 58-65
S-Palmitoylation of the serotonin transporter promotes its cell surface expression and serotonin uptake
- Open Access
- 5 September 2022
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 143 (2) , 317-327.e6
S-Palmitoylation of Tyrosinase at Cysteine500 Regulates Melanogenesis
- 5 September 2022
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 143 (2) , 317-327.e6
Open AccessS-Palmitoylation of Tyrosinase at Cysteine500 Regulates Melanogenesis
- Open Access
- 1 February 2019
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 294 (7) , 2569-2578
Differential S-palmitoylation of the human and rodent β3-adrenergic receptors
- 1 February 2019
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 294 (7) , 2569-2578
Open AccessDifferential S-palmitoylation of the human and rodent β3-adrenergic receptors
- Open Access
- 1 September 2018
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 293 (38) , 14758-14774
Pharmacological induction of heat shock proteins ameliorates toxicity of mutant PKCγ in spinocerebellar ataxia type 14
- 1 September 2018
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 293 (38) , 14758-14774
Open AccessPharmacological induction of heat shock proteins ameliorates toxicity of mutant PKCγ in spinocerebellar ataxia type 14
- Open Access
- 1 May 2018
- Published by Elsevier in Journal of Pharmacological Sciences
- Vol. 137 (1) , 20-29
Propofol induced diverse and subtype-specific translocation of PKC families
- 1 May 2018
- Published by Elsevier in Journal of Pharmacological Sciences
- Vol. 137 (1) , 20-29
Open AccessPropofol induced diverse and subtype-specific translocation of PKC families
- Open Access
- 22 November 2017
- Published by Society for Neuroscience in The Journal of Neuroscience
- Vol. 38 (2) , 278-290
The Role of Cysteine String Protein α Phosphorylation at Serine 10 and 34 by Protein Kinase Cγ for Presynaptic Maintenance
Protein kinase Cγ (PKCγ) knock-out (KO) animals exhibit symptoms of Parkinson's disease (PD), including dopaminergic neuronal loss in the substantia nigra. However, the PKCγ substrates responsible for the survival of dopaminergic neuronsin vivohave not yet been elucidated. Previously, we found 10 potent substrates in the striatum of PKCγ-KO mice. Here, we focused on cysteine string protein α (CSPα), a protein from the heat shock protein (HSP) 40 cochaperone families localized on synaptic vesicles. We found that in cultured cells, PKCγ phosphorylates CSPα at serine (Ser) 10 and Ser34. Additionally, apoptosis was found to have been enhanced by the overexpression of a phosphorylation-null mutant of CSPα, CSPα(S10A/S34A). Compared with wild-type (WT) CSPα, the CSPα(S10A/S34A) mutant had a weaker interaction with HSP70. However, in sharp contrast, a phosphomimetic CSPα(S10D/S34D) mutant, compared with WT CSPα, had a stronger interaction with HSP70. In addition, total levels of synaptosomal-associated protein (SNAP) 25, a main downstream target of the HSC70/HSP70 chaperone complex, were found to have decreased by the CSPα(S10A/S34A) mutant through increased ubiquitination of SNAP25 in PC12 cells. In the striatum of 2-year-old male PKCγ-KO mice, decreased phosphorylation levels of CSPα and decreased SNAP25 protein levels were observed. These findings indicate the phosphorylation of CSPα by PKCγ may protect the presynaptic terminal from neurodegeneration. The PKCγ–CSPα–HSC70/HSP70–SNAP25 axis, because of its role in protecting the presynaptic terminal, may provide a new therapeutic target for the treatment of PD.SIGNIFICANCE STATEMENTCysteine string protein α (CSPα) is a protein belonging to the heat shock protein (HSP) 40 cochaperone families localized on synaptic vesicles, which maintain the presynaptic terminal. However, the function of CSPα phosphorylation by protein kinase C (PKC) for neuronal cell survival remains unclear. The experiments presented here demonstrate that PKCγ phosphorylates CSPα at serine (Ser) 10 and Ser34. CSPα phosphorylation at Ser10 and Ser34 by PKCγ protects the presynaptic terminal by promoting HSP70 chaperone activity. This report suggests that CSPα phosphorylation, because of its role in modulating HSP70 chaperone activity, may be a target for the treatment of neurodegeneration.
- 22 November 2017
- Published by Society for Neuroscience in The Journal of Neuroscience
- Vol. 38 (2) , 278-290
Open AccessThe Role of Cysteine String Protein α Phosphorylation at Serine 10 and 34 by Protein Kinase Cγ for Presynaptic Maintenance
Protein kinase Cγ (PKCγ) knock-out (KO) animals exhibit symptoms of Parkinson's disease (PD), including dopaminergic neuronal loss in the substantia nigra. However, the PKCγ substrates responsible for the survival of dopaminergic neuronsin vivohave not yet been elucidated. Previously, we found 10 potent substrates in the striatum of PKCγ-KO mice. Here, we focused on cysteine string protein α (CSPα), a protein from the heat shock protein (HSP) 40 cochaperone families localized on synaptic vesicles. We found that in cultured cells, PKCγ phosphorylates CSPα at serine (Ser) 10 and Ser34. Additionally, apoptosis was found to have been enhanced by the overexpression of a phosphorylation-null mutant of CSPα, CSPα(S10A/S34A). Compared with wild-type (WT) CSPα, the CSPα(S10A/S34A) mutant had a weaker interaction with HSP70. However, in sharp contrast, a phosphomimetic CSPα(S10D/S34D) mutant, compared with WT CSPα, had a stronger interaction with HSP70. In addition, total levels of synaptosomal-associated protein (SNAP) 25, a main downstream target of the HSC70/HSP70 chaperone complex, were found to have decreased by the CSPα(S10A/S34A) mutant through increased ubiquitination of SNAP25 in PC12 cells. In the striatum of 2-year-old male PKCγ-KO mice, decreased phosphorylation levels of CSPα and decreased SNAP25 protein levels were observed. These findings indicate the phosphorylation of CSPα by PKCγ may protect the presynaptic terminal from neurodegeneration. The PKCγ–CSPα–HSC70/HSP70–SNAP25 axis, because of its role in protecting the presynaptic terminal, may provide a new therapeutic target for the treatment of PD.SIGNIFICANCE STATEMENTCysteine string protein α (CSPα) is a protein belonging to the heat shock protein (HSP) 40 cochaperone families localized on synaptic vesicles, which maintain the presynaptic terminal. However, the function of CSPα phosphorylation by protein kinase C (PKC) for neuronal cell survival remains unclear. The experiments presented here demonstrate that PKCγ phosphorylates CSPα at serine (Ser) 10 and Ser34. CSPα phosphorylation at Ser10 and Ser34 by PKCγ protects the presynaptic terminal by promoting HSP70 chaperone activity. This report suggests that CSPα phosphorylation, because of its role in modulating HSP70 chaperone activity, may be a target for the treatment of neurodegeneration.
- Open Access
Loss of the Phenolic Hydroxyl Group and Aromaticity from the Side Chain of Anti-Proliferative 10-Methyl-aplog-1, a Simplified Analog of Aplysiatoxin, Enhances Its Tumor-Promoting and Proinflammatory Activities
Aplysiatoxin (ATX) is a protein kinase C (PKC) activator with potent tumor-promoting activity. In contrast, 10-methyl-aplog-1 (1), a simplified analog of ATX, was anti-proliferative towards several cancer cell lines without significant tumor-promoting and proinflammatory activities. To determine the effects of the phenolic group on the biological activities of 1, we synthesized new derivatives (2, 3) that lack the phenolic hydroxyl group and/or the aromatic ring. Compound 2, like 1, showed potent anti-proliferative activity against several cancer cell lines, but little with respect to tumor-promoting and proinflammatory activities. In contrast, 3 exhibited weaker growth inhibitory activity, and promoted inflammation and tumorigenesis. The binding affinity of 3 for PKCδ, which is involved in growth inhibition and apoptosis, was several times lower than those of 1 and 2, possibly due to the absence of the hydrogen bond and CH/π interaction between its side chain and either Met-239 or Pro-241 in the PKCδ-C1B domain. These results suggest that both the aromatic ring and phenolic hydroxyl group can suppress the proinflammatory and tumor-promoting activities of 1 and, therefore, at least the aromatic ring in the side chain of 1 is indispensable for developing anti-cancer leads with potent anti-proliferative activity and limited side effects. In accordance with the binding affinity, the concentration of 3 necessary to induce PKCδ-GFP translocation to the plasma membrane and perinuclear regions in HEK293 cells was higher than that of 1 and 2. However, the translocation profiles for PKCδ-GFP due to induction by 1–3 were similar.
Open AccessLoss of the Phenolic Hydroxyl Group and Aromaticity from the Side Chain of Anti-Proliferative 10-Methyl-aplog-1, a Simplified Analog of Aplysiatoxin, Enhances Its Tumor-Promoting and Proinflammatory Activities
Aplysiatoxin (ATX) is a protein kinase C (PKC) activator with potent tumor-promoting activity. In contrast, 10-methyl-aplog-1 (1), a simplified analog of ATX, was anti-proliferative towards several cancer cell lines without significant tumor-promoting and proinflammatory activities. To determine the effects of the phenolic group on the biological activities of 1, we synthesized new derivatives (2, 3) that lack the phenolic hydroxyl group and/or the aromatic ring. Compound 2, like 1, showed potent anti-proliferative activity against several cancer cell lines, but little with respect to tumor-promoting and proinflammatory activities. In contrast, 3 exhibited weaker growth inhibitory activity, and promoted inflammation and tumorigenesis. The binding affinity of 3 for PKCδ, which is involved in growth inhibition and apoptosis, was several times lower than those of 1 and 2, possibly due to the absence of the hydrogen bond and CH/π interaction between its side chain and either Met-239 or Pro-241 in the PKCδ-C1B domain. These results suggest that both the aromatic ring and phenolic hydroxyl group can suppress the proinflammatory and tumor-promoting activities of 1 and, therefore, at least the aromatic ring in the side chain of 1 is indispensable for developing anti-cancer leads with potent anti-proliferative activity and limited side effects. In accordance with the binding affinity, the concentration of 3 necessary to induce PKCδ-GFP translocation to the plasma membrane and perinuclear regions in HEK293 cells was higher than that of 1 and 2. However, the translocation profiles for PKCδ-GFP due to induction by 1–3 were similar.
- Open Access
- 24 February 2017
- Published by Wiley in Genes to Cells
- Vol. 22 (3) , 310-327
Xeroderma pigmentosum group C protein interacts with histones: regulation by acetylated states of histone H3
In the mammalian global genome nucleotide excision repair pathway, two damage recognition factors, XPC and UV‐DDB, play pivotal roles in the initiation of the repair reaction. However, the molecular mechanisms underlying regulation of the lesion recognition process in the context of chromatin structures remain to be understood. Here, we show evidence that damage recognition factors tend to associate with chromatin regions devoid of certain types of acetylated histones. Treatment of cells with histone deacetylase inhibitors retarded recruitment of XPC to sites of UV‐induced DNA damage and the subsequent repair process. Biochemical studies showed novel multifaceted interactions of XPC with histone H3, which were profoundly impaired by deletion of the N‐terminal tail of histone H3. In addition, histone H1 also interacted with XPC. Importantly, acetylation of histone H3 markedly attenuated the interaction with XPC in vitro, and local UV irradiation of cells decreased the level of H3K27ac in the damaged areas. Our results suggest that histone deacetylation plays a significant role in the process of DNA damage recognition for nucleotide excision repair and that the localization and functions of XPC can be regulated by acetylated states of histones.
- 24 February 2017
- Published by Wiley in Genes to Cells
- Vol. 22 (3) , 310-327
Open AccessXeroderma pigmentosum group C protein interacts with histones: regulation by acetylated states of histone H3
In the mammalian global genome nucleotide excision repair pathway, two damage recognition factors, XPC and UV‐DDB, play pivotal roles in the initiation of the repair reaction. However, the molecular mechanisms underlying regulation of the lesion recognition process in the context of chromatin structures remain to be understood. Here, we show evidence that damage recognition factors tend to associate with chromatin regions devoid of certain types of acetylated histones. Treatment of cells with histone deacetylase inhibitors retarded recruitment of XPC to sites of UV‐induced DNA damage and the subsequent repair process. Biochemical studies showed novel multifaceted interactions of XPC with histone H3, which were profoundly impaired by deletion of the N‐terminal tail of histone H3. In addition, histone H1 also interacted with XPC. Importantly, acetylation of histone H3 markedly attenuated the interaction with XPC in vitro, and local UV irradiation of cells decreased the level of H3K27ac in the damaged areas. Our results suggest that histone deacetylation plays a significant role in the process of DNA damage recognition for nucleotide excision repair and that the localization and functions of XPC can be regulated by acetylated states of histones.